Matthew Kang

422 citations
7 papers · 244 indexed · h-index 5
Topics
Heparin-Induced Thrombocytopenia and Thrombosis (2 papers)Immunodeficiency and Autoimmune Disorders (2 papers)Blood disorders and treatments (2 papers)
Partner nations
CanadaUnited States

In The Last Decade

Matthew Kang

7 papers receiving 239 citations

Peers

Matthew Kang
Comparison fields: 5 of 36
  • Surgery 123
  • Orthopedics and Sports Medicine 93
  • Internal Medicine 62
  • Emergency Medicine 53
  • Hematology 50
Replace Thomas Skjødt with:
Thomas Skjødt Denmark
Dieter Dauwe Belgium
Brenda Buzzard United Kingdom
Newton C. McCollough United States
Athena Plagou Greece
Koushik Narayan Subramanyam India
Mamun Al-Rashid United Kingdom
Jean Michel Serfaty France
Shahan Yacoubian United States
Erhan Serin Türkiye
Matthew Kang relative to Thomas Skjødt Denmark Thomas Skjødt's profile →
Citations per field
00.5×10×15×20.7×
Thomas Skjødt · 1×
Citations per year

Countries citing papers authored by Matthew Kang

Since Specialization
Citations

This map shows the geographic impact of Matthew Kang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew Kang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew Kang more than expected).

Fields of papers citing papers by Matthew Kang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew Kang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew Kang. The network helps show where Matthew Kang may publish in the future.

Co-authorship network of co-authors of Matthew Kang

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew Kang. A scholar is included among the top collaborators of Matthew Kang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew Kang. Matthew Kang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
#WorkIndexed citations
1 23
2 95
3 32
4 86
5 2
6 5
7 1

About Matthew Kang

Matthew Kang is a scholar working on Internal Medicine, Hematology and Orthopedics and Sports Medicine, having authored 7 papers that have together received 244 indexed citations. Recurring topics across this work include Heparin-Induced Thrombocytopenia and Thrombosis (2 papers), Immunodeficiency and Autoimmune Disorders (2 papers) and Blood disorders and treatments (2 papers). The work is most often cited by research in Internal Medicine (62 citations), Orthopedics and Sports Medicine (93 citations) and Emergency Medicine (53 citations). Matthew Kang has collaborated with scholars based in Canada and United States. Frequent co-authors include Mark A. Feger, Luke Donovan, Michael J. Kovacs, Alejandro Lazo‐Langner, Ian Chin‐Yee, Cyrus C. Hsia, Mohammed Quader, Leila Rezai Gharai, John D. Grizzard and Zachary M. Gertz. Their work appears in journals such as Blood, Transfusion and Journal of Cardiac Failure.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026